PACS Group, Inc. (NYSE:PACS – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eight ratings firms that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $34.00.
Several analysts have recently commented on PACS shares. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $18.00 price target on shares of PACS Group in a research report on Tuesday, December 17th. Macquarie reduced their target price on PACS Group from $42.00 to $24.00 and set an “outperform” rating on the stock in a research report on Monday, January 6th. Stephens lowered their price target on PACS Group from $48.00 to $31.00 and set an “overweight” rating for the company in a report on Monday, November 18th. Truist Financial reduced their price objective on shares of PACS Group from $46.00 to $32.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Finally, UBS Group started coverage on shares of PACS Group in a research report on Wednesday, October 9th. They issued a “buy” rating and a $50.00 target price on the stock.
Get Our Latest Stock Report on PACS
Institutional Trading of PACS Group
PACS Group Trading Up 4.2 %
PACS stock opened at $13.37 on Friday. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 0.82. The firm has a 50-day moving average of $15.69 and a two-hundred day moving average of $29.69. PACS Group has a 12 month low of $12.54 and a 12 month high of $43.92.
About PACS Group
PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.
Read More
- Five stocks we like better than PACS Group
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- Why Invest in High-Yield Dividend Stocks?
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- What is the FTSE 100 index?
- Delta Can Fly to New Highs in 2025; Here’s Why
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.